Association of the MELAS m.3243A>G mutation with myositis and the superiority of urine over muscle, blood and hair for mutation detection

Journal of Clinical Neuroscience

Volumn 16, Issue 9, 2009, Pages 1223-1225

  Marotta, Rosetta ^a   Reardon, Katrina ^a   McKelvie, Penny A ^a   Chiotis, Maria ^a   Chin, Judy ^a   Cook, Mark ^a   Collins, Steven J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Cytochrome oxidase; Mitochondria; Mutation; Myositis; Urine

Indexed keywords

CYTOCHROME C OXIDASE;

ADULT; ARTICLE; BLOOD; CASE REPORT; CONTROLLED STUDY; FEMALE; GENE MUTATION; HAIR; HUMAN; HUMAN TISSUE; LIMB WEAKNESS; MELAS SYNDROME; MUSCLE; MUTATIONAL ANALYSIS; MYALGIA; MYOSITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKELETAL MUSCLE; URINE;

BIOPSY; DNA, MITOCHONDRIAL; FEMALE; HAIR; HUMANS; MELAS SYNDROME; MIDDLE AGED; MUSCLE, SKELETAL; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 67650747339     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.11.012     Document Type: Article

References (8)

1. Ruiz-Pesini E, Lott MT, Procaccio V, et al., An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Research 35 (Database issue) 2007:D823-D828. URL: http://www.mitomap.org.
2. Ciafaloni E., Ricci E., Servidei S., et al. MELAS: Clinical features, biochemistry, and molecular genetics. Ann Neurol 31 (1992) 391-398
3. Goto Y., Nonaka I., and Horai Y. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
4. Frederiksen A.L., Andersen P.H., Kyvik K.O., et al. Tissue specific distribution of the 3243A>G mtDNA mutation. J Med Genet 43 (2006) 671-677
5. Bernier F.P., Boneh X., Dennett X., et al. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59 (2002) 1406-1411
6. Kärrpa M. Myopathy and peripheral neuropathy associated with the 3243A>G mutation in mitochondrial DNA. Oulu University Press, 2004: 72 http://herkules.oulu.fi/isbn9514273648/.
7. Clark D.W.J., and Strandell J. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?. Eur J Clin Pharmacol 62 (2006) 473-479
8. Blume G., Pestronak A., Frank B., et al. Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 120 (1997) 39-45